Artigo de periodico

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo (2023)

• Authors:
  • Silvestre, Renata Nacasaki
  • Eitler, Jiri
  • Azevedo, Júlia Teixeira Cottas de
  • Tirapelle, Mariane Cariati
  • Fantacini, Daianne Maciely Carvalho
  • Souza, Lucas Eduardo Botelho de
  • Swiech, Kamilla
  • Covas, Dimas Tadeu
  • Calado, Rodrigo Tocantins
  • Montero, Paola Ortiz
  • Malmegrim, Kelen Cristina Ribeiro
  • Figueiredo, Marxa L.
  • Tonn, Torsten
  • Picanço-Castro, Virgínia
• USP affiliated authors: SOUZA, LUCAS EDUARDO BOTELHO DE - FMRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; COVAS, DIMAS TADEU - FMRP ; RODRIGUES, RODRIGO DO TOCANTINS CALADO DE SALOMA - FMRP ; CASTRO, VIRGÍNIA PICANÇO E - FMRP ; TIRAPELLE, MARIANE CARIATI - FMRP
• Unidades: FMRP; FCFRP
• DOI: 10.3389/fimmu.2023.1226518
• Subjects: ANTÍGENOS; LINHAGEM CELULAR; PROLIFERAÇÃO CELULAR; INTERLEUCINAS
• Keywords: B-cell malignances; CAR-NK cells; IL-15; IL-15 receptor; NK-92; Adoptive cell therapy; Allogeneic therapy
• Agências de fomento:
  • Financiamento FAPESP
  • Financiamento CNPq
  • Financiamento CAPES
  • Financiamento BMBF
• Language: Inglês
• Imprenta:
  • Publisher place: Lausanne
  • Date published: 2023
• Source:
  • Título: Frontiers in Immunology
  • ISSN: 1664-3224
  • Volume/Número/Paginação/Ano: v. 14, art. 1226518, p. 1-15, 2023


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	003193634.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SILVESTRE, Renata Nacasaki et al. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, v. 14, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1226518. Acesso em: 02 abr. 2026.

• APA

  Silvestre, R. N., Eitler, J., Azevedo, J. T. C. de, Tirapelle, M. C., Fantacini, D. M. C., Souza, L. E. B. de, et al. (2023). Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo. Frontiers in Immunology, 14, 1-15. doi:10.3389/fimmu.2023.1226518

• NLM

  Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2026 abr. 02 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518

• Vancouver

  Silvestre RN, Eitler J, Azevedo JTC de, Tirapelle MC, Fantacini DMC, Souza LEB de, Swiech K, Covas DT, Calado RT, Montero PO, Malmegrim KCR, Figueiredo ML, Tonn T, Picanço-Castro V. Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo [Internet]. Frontiers in Immunology. 2023 ; 14 1-15.[citado 2026 abr. 02 ] Available from: https://doi.org/10.3389/fimmu.2023.1226518

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Successful use of human AB serum to support the expansion of adipose tissue-derived mesenchymal stem/stromal cell in a microcarrier-based platform
• Serum-free suspension adaptation of HEK-293T cells: basis for large-scale biopharmaceutical production
• Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model
• Anti-mage-a4 car nk cell therapy for the treatment of solid tumors
• Production of recombinant coagulation factors:: are humans the best host cells?
• Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells
• A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
• Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11
• Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers
• Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems